The global injectable cement market was valued at $1,321.7 million in 2021, and is projected to reach $2,297.0 million by 2031, registering a CAGR of 5.7% from 2022 to 2031. Injectable cement is the synthetic materials used for filling spaces between the prosthesis and bone and provides elasticity. It is used as an adhesive in hip replacement surgery to keep implant in place. It is also used to provide strength for bone stability. Injectable cement is biocompatible and osteoconductive synthetic materials. There are different types of bone cement that are classified on the basis of viscosity, such as low viscosity cement, medium viscosity cement, and highly viscous cement. The viscosity of bone cement affects its properties, including handling time, fixing quality, bone penetration, and stability. Currently available injectable cement includes, calcium sulfate cement and polymethylmethacrylate (PMMA).
The injectable cement market growth is driven by rise in geriatric population, increase in accidental cases, and surge in surgeries performed for hip replacement. For instance, according to the National Highway Traffic Safety Administration (NHTSA), a noticeable increase of 10.5% fatalities was reported in 2021 in the U. S. Furthermore, according to Organisation for Economic Co-operation and Development (OCED) library, in 2019, Germany, Austria, Finland, and Switzerland were among the countries with highest rates for hip and knee replacement. In addition, as per the same source, hip replacement rates increased by 22% between 2009 and 2019 in OECD countries. Moreover, rise in demand for injectable cement drives the growth of the market. In addition, increase in use of injectable cement in the dentistry sector is anticipated to contribute toward the growth of the market. Furthermore, rise in prevalence of bone diseases leads to increase in the number of orthopedic surgeries, which further fosters the market growth.
Moreover, increase in prevalence of bone diseases, such as bone infection, bone tumor, and osteoporosis, leads to increase in the number of orthopedic surgeries, which further fosters the market growth.
However, the high cost associated with surgery and shortage of skilled surgeons hinder the growth of the market. For instance, the cost of total knee replacement surgery without insurance is about $19,995 in the U. S. Moreover, clinical barriers of injectable cement and low penetration act as a major restraint of the global injectable cement market. On the other side, increase in healthcare expenditure and increase in the number of specialized hospitals in countries, such as China and India are expected to create opportunities for the growth of the market.
The injectable cement market is segmented into type, application, end user, and region. By type, the market is segregated into low viscosity cement, medium viscosity cement, and high viscosity cement. On the basis of application, the market is categorized into spine fusion, bone fracture, and others. The others segment includes, craniomaxillofacial and dental bone grafting. Depending on end user, the market is fragmented into hospital, clinics, and others. The others segment includes, research centers and spine centers. Region-wise, the market is analyzed across North America (U. S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
Major key players that operate in the global injectable cement market are Arthrex Inc., B. Braun Melsungen AG, Cook Medical, Enovis, Johnson and Johnson, Medacta International SA, Medtronic plc, Smith and Nephew, Stryker Corporation, and Teknimed.
The injectable cement market growth is driven by rise in geriatric population, increase in accidental cases, and surge in surgeries performed for hip replacement. For instance, according to the National Highway Traffic Safety Administration (NHTSA), a noticeable increase of 10.5% fatalities was reported in 2021 in the U. S. Furthermore, according to Organisation for Economic Co-operation and Development (OCED) library, in 2019, Germany, Austria, Finland, and Switzerland were among the countries with highest rates for hip and knee replacement. In addition, as per the same source, hip replacement rates increased by 22% between 2009 and 2019 in OECD countries. Moreover, rise in demand for injectable cement drives the growth of the market. In addition, increase in use of injectable cement in the dentistry sector is anticipated to contribute toward the growth of the market. Furthermore, rise in prevalence of bone diseases leads to increase in the number of orthopedic surgeries, which further fosters the market growth.
Moreover, increase in prevalence of bone diseases, such as bone infection, bone tumor, and osteoporosis, leads to increase in the number of orthopedic surgeries, which further fosters the market growth.
However, the high cost associated with surgery and shortage of skilled surgeons hinder the growth of the market. For instance, the cost of total knee replacement surgery without insurance is about $19,995 in the U. S. Moreover, clinical barriers of injectable cement and low penetration act as a major restraint of the global injectable cement market. On the other side, increase in healthcare expenditure and increase in the number of specialized hospitals in countries, such as China and India are expected to create opportunities for the growth of the market.
The injectable cement market is segmented into type, application, end user, and region. By type, the market is segregated into low viscosity cement, medium viscosity cement, and high viscosity cement. On the basis of application, the market is categorized into spine fusion, bone fracture, and others. The others segment includes, craniomaxillofacial and dental bone grafting. Depending on end user, the market is fragmented into hospital, clinics, and others. The others segment includes, research centers and spine centers. Region-wise, the market is analyzed across North America (U. S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
Major key players that operate in the global injectable cement market are Arthrex Inc., B. Braun Melsungen AG, Cook Medical, Enovis, Johnson and Johnson, Medacta International SA, Medtronic plc, Smith and Nephew, Stryker Corporation, and Teknimed.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the injectable cement market analysis from 2021 to 2031 to identify the prevailing injectable cement market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the injectable cement market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global injectable cement market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- High Viscosity Cement
- Low Viscosity Cement
- Medium Viscosity Cement
By Application
- Spine Fusion
- Bone fracture
- Others
By End User
- Hospital
- Clinics
- Others
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Arthrex
- cook medical
- Enovis (DJO Global, Inc. )
- johnson and johnson md&d
- Medacta International SA
- smith and nephew
- Stryker Corporation
- B. Braun Melsungen AG
- Medtronic plc
- Teknimed
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: INJECTABLE CEMENT MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Low Viscosity Cement
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Medium Viscosity Cement
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4 High Viscosity Cement
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
CHAPTER 5: INJECTABLE CEMENT MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Spine Fusion
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Bone fracture
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
CHAPTER 6: INJECTABLE CEMENT MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Clinics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: INJECTABLE CEMENT MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Type
7.2.5.1.3 Market size and forecast, by Application
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Type
7.2.5.2.3 Market size and forecast, by Application
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Type
7.2.5.3.3 Market size and forecast, by Application
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Type
7.3.5.1.3 Market size and forecast, by Application
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Type
7.3.5.2.3 Market size and forecast, by Application
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Type
7.3.5.3.3 Market size and forecast, by Application
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Type
7.3.5.4.3 Market size and forecast, by Application
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Type
7.3.5.5.3 Market size and forecast, by Application
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Type
7.3.5.6.3 Market size and forecast, by Application
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Type
7.4.5.1.3 Market size and forecast, by Application
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Type
7.4.5.2.3 Market size and forecast, by Application
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Type
7.4.5.3.3 Market size and forecast, by Application
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 Australia
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Type
7.4.5.4.3 Market size and forecast, by Application
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Type
7.4.5.5.3 Market size and forecast, by Application
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Type
7.4.5.6.3 Market size and forecast, by Application
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Type
7.5.5.1.3 Market size and forecast, by Application
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Type
7.5.5.2.3 Market size and forecast, by Application
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Type
7.5.5.3.3 Market size and forecast, by Application
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Type
7.5.5.4.3 Market size and forecast, by Application
7.5.5.4.4 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Arthrex
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 cook medical
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Enovis (DJO Global, Inc.)
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 johnson and johnson md&d
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Medacta International SA
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 smith and nephew
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Stryker Corporation
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 B. Braun Melsungen AG
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Medtronic plc
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Teknimed
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Injectable Cement Market,' the global injectable cement market size was valued at $1,321.7 million in 2021, and is projected to reach $2,297.0 million by 2031, registering a CAGR of 5.7% from 2022 to 2031. Injectable cement, also known as bone cement, is the material that consist of a powder and liquid, which is used to fill the gap between bone and implant. It is widely used in joint replacement surgery and provides temporary as well as permanent solution to bone fractures. In 1070’s, the U.S. Food and Drug Administration (FDA) approved bone cement for use in knee and hip prosthetic fixation. The function of injectable cement is to transfer the load from the implant to the bone.Factors that drive the growth of global injectable cement market share include, increase in number of orthopedic surgeries, increase in number of road accident cases, and growing number of orthopedic centers and hospital that use injectable cement. Moreover, increase in R&D activities in the healthcare sector and rise in demand for injectable cement drive the growth of the market. For instance, according to the report shared by the International Osteoporosis Foundation (IOF), estimated change in the annual number of osteoporotic fractures from 2019 to 2034 is 24.8%, is expected to reach to 5.34 million in 2034 from 4.3 million in 2019. Furthermore, growing incidences of hip fractures also contributes towards the injectable cement market trends. For instance, according to an article published by American Academy of Orthopaedic Surgeons, in November 2020, about 300,000 people in the U.S. sustain a hip fracture and most of these fractures occur in patients aged 65 years and above every year.
Moreover, chronic orthopedic diseases require surgeries, such as hip and knee replacements. In such surgeries, injectable cement is used to fill gaps in bone. Therefore, increase in number of knee replacement surgeries, and increase in number of injectable cement industry fuels the market growth. For instance, in Canada, the knee and hip replacement surgery is the second most common surgery, as per the report shared by the Canadian Joint Replacement Registry (CJRR). Approximately more than 75,000 knee replacement and 63,000 hip replacement surgeries were performed in Canada from 2019 to 2020. This report further states 2.4% increase in the hip replacement surgery from 2019 to 2020.
However, high cost of surgery is anticipated to act as a major restraint of the global injectable cement market size. Furthermore, people are travelling globally to get their treatment done at affordable prices. Thus, increase in number of specialized hospitals in countries, such as Singapore, Japan, China, and India provide good treatment at affordable price, which encourages patients to travel globally.
On the basis of type, the injectable cement market analysis is segmented into low viscosity cement, medium viscosity cement, and high viscosity cement. Depending on application, the market is fragmented into spine fusion, bone fracture, and others. As per end user, the market is differentiated into hospital, clinics, and others. By region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of type, the market is classified into low viscosity cement, medium viscosity cement, and high viscosity cement. The high viscosity cement was the highest revenue contributor to the market in 2021, and is the fastest growing segment during the forecast period, owing to excellent mechanical properties, low degradation properties, and rise in demand for high viscosity bone cement.
On the basis of application, the market is classified into spine fusion, bone fracture, and others. The bone fracture segment dominated the market in 2021, and is expected to be the fastest growing segment during the injectable cement market forecast period, owing to rise in incidences of bone fractures due to road accidents and osteoporosis.
On the basis of end user, the market is classified into hospital, clinics, and others. The hospitals segment dominated the market in 2021, and is expected grow at fastest rate during the forecast period, owing to rise in number of orthopedic surgeries performed in hospitals and increase in initiatives taken by government to develop healthcare infrastructure.
Region-wise, North America has the highest injectable cement market share in 2021, and is expected to maintain its lead during the forecast period, owing to higher adoption of synthetic injectable cement, rise in geriatric population, availability of well-developed healthcare infrastructure, and wide availability of injectable cement. However, Asia-Pacific is expected to exhibit the fastest growth during the forecast period, owing to surge in sport injuries and accident incidences, rise in awareness about use of injectable cement, and surge in healthcare expenditure.
The overall impact of the COVID-19 pandemic remained negative for injectable cement industry in the injectable cement market. For instance, Canadian Institute for Health Information, in 2019-2020, reported that there was a decrease in number of hip replacements and knee arthroplasty in Canada. This represents 16.1% decrease in hip replacement and a 29.8% decrease in knee arthroplasty surgeries between April and December 2020. The total daily hospital medicare revenue for arthroplasty declined by 87%. However, the market was anticipated to witness recovery in 2021 and beyond, and show stable growth for injectable cement in the coming future.
Key Findings of The Study
By type, the high viscosity cement segment dominated the market in 2021.On the basis of application, the bone fracture segment dominated the market in 2021.
By end user, the hospital segment dominated the market in 2021.
By region, North America dominated the market in 2021 and is expected to grow at a CAGR of 5.2%.
Companies Mentioned
- Arthrex
- Cook Medical
- Enovis (Djo Global, Inc.)
- Johnson and Johnson Md&D
- Medacta International SA
- Smith and Nephew
- Stryker Corporation
- B. Braun Melsungen AG
- Medtronic PLC
- Teknimed
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 226 |
| Published | October 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 1321.7 million |
| Forecasted Market Value ( USD | $ 2297 million |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
